Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy

Hepatology Research

Volumn 41, Issue 10, 2011, Pages 946-954

  Arase, Yasuji ^a   Suzuki, Fumitaka ^a   Kawamura, Yusuke ^a   Suzuki, Yoshiyuki ^a   Kobayashi, Masahiro ^a   Matsumoto, Naoki ^a   Akuta, Norio ^a   Sezaki, Hitomi ^a   Hosaka, Tetsuya ^a   Ogawa, Kyoko ^a   Imai, Norihiro ^a   Seko, Yuya ^a   Saito, Satoshi ^a   Ikeda, Kenji ^a   Kobayashi, Mariko ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Chronic kidney disease; Hepatitis C virus; Liver cirrhosis

Indexed keywords

CREATININE; INTERFERON; RIBAVIRIN;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEPATITIS C; HUMAN; KIDNEY FAILURE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 80053269633     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00845.x     Document Type: Article

References (33)

1. Colombo M, Kuo G, Choo QL etal. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 1006-8.
2. Hasan F, Jeffers LJ, De Medina M etal. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990; 12: 589-91.
3. Tsukuma H, Hiyama T, Tanaka S etal. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797-801.
4. Ikeda K, Saitoh S, Koida I etal. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18: 47-53.
5. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease- review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-20.
6. Pawlotsky JM, Roudot-Thoraval F, Simmonds P etal. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169-73.
7. Arase Y, Suzuki F, Suzuki Y etal. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology 2009; 49: 739-44.
8. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-5.
9. Johnson RJ, Gretch DR, Yamabe H etal. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-70.
10. Yamabe H, Johnson RJ, Gretch DR etal. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-alpha. Am J Kidney Dis 1995; 25: 67-9.
11. Arase Y, Ikeda K, Murashima N etal. Glomerulonephritis in autopsy cases with hepatitis C virus infection. Int Med 1998; 37: 836-40.
12. Arase Y, Ikeda K, Tubota A etal. Serum levels of γ-globulin and total bilirubin influence the prevalence of multiple extrahepatic complication in patients with hepatitis C virus infection. Hepatol Res 2003; 25: 14-21.
13. Fabrizi F, Lunghi G, Messa P, Martin P. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 2008; 21: 813-25.
14. Martin P, Fabrizi F. Hepatitis C virus and kidney disease. J Hepatol 2008; 49: 613-24.
15. Ahmed MS, Wong CF, Shawki H, Kapoor N, Pandya BK. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature. Clin Nephrol 2008; 69: 298-301.
16. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
17. Coresh J, Selvin E, Stevens LA etal. Prevalence of chronic kidney disease awareness, prevalence, and trends among U.S. adults 1999 to 2000. JAMA 2007; 298: 2038-47.
18. Tsui JI, Vittinghoff E, Shlipak MG etal. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med 2007; 167: 1271-6.
19. Tsui JI, Vittinghoff E, Shlipak MG, O'Hare AM. Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2006; 17: 1168-74.
20. Dalrymple LS, Koepsell T, Sampson J etal. Hepatitis C virus infection and the prevalence of renal insufficiency. Clin J Am Soc Nephrol 2007; 2: 715-21.
21. Babor TF, Caetano R. The trouble with alcohol abuse: What are we trying to measure, diagnose, count and prevent? Addiction 2008; 103: 1057-105.
22. Imai E, Horio M, Nitta K etal. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007; 11: 41-50.
23. Imai E, Horio M, Iseki K etal. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 2007; 11: 156-63.
24. Genuth S, Alberti KG, Bennett P etal. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-7.
25. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Sheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
26. Fleming TR, Harrington DP, O'Brien PC. Designs for group sequential tests. Control Clin Trials 1984; 5: 348-61.
27. Raanani P, Ben-Bassat I. Immune-mediated complications during interferon therapy in hematological patients. Acta Haematol 2002; 107: 133-44.
28. Lhotta K. Beyond hepatorenal syndrome: glomerulonephritis in patients with liver disease. Semin Nephrol 2002; 22: 302-8.
29. Alpers CE, Kowalewska J. Emerging paradigms in the renal pathology of viral diseases. Clin J Am Soc Nephrol 2007; 2 (Suppl 1): S6-S12.
30. Wörnle M, Schmid H, Banas B etal. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 2006; 168: 370-85.
31. Shintani Y, Fujie H, Miyoshi H etal. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840-8.
32. Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 2006; 26: 232-44.
33. Ishizaka N, Ishizaka Y, Seki G, Nagai R, Yamakado M, Koike K. Association between hepatitis B/C viral infection, chronic kidney disease and insulin resistance in individuals undergoing general health screening. Hepatol Res 2008; 38: 775-83.